Vincristine and fine motor function of children with acute lymphoblastic leukemia

被引:9
|
作者
Sabarre, Cheryl L. [1 ]
Rassekh, Shahrad R. [2 ,3 ]
Zwicker, Jill G. [4 ]
机构
[1] British Columbia Childrens Hosp, Bone Marrow Transplant Program, Vancouver, BC V6H 3V4, Canada
[2] British Columbia Childrens Hosp, Vancouver, BC V6H 3V4, Canada
[3] Univ British Columbia, Fac Med, Vancouver, BC V6H 3V4, Canada
[4] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC V6H 3V4, Canada
关键词
Activities of daily living; Movement Assessment Battery for Children-2; Motor skills; Oncology; Pediatrics; MOVEMENT ASSESSMENT BATTERY; THERAPY; PERFORMANCE; SURVIVORS; VALIDITY; DECREASE; CANCER;
D O I
10.1177/0008417414539926
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Background. Children with acute lymphoblastic leukemia receive vincristine, a chemotherapy drug known to cause peripheral neuropathy. Yet, few studies have examined the association of vincristine to fine motor function. Purpose. This study will describe the fine motor skills and function of children with acute lymphoblastic leukemia on maintenance vincristine. Method. A prospective case series design assessed manual dexterity and parent-reported fine motor dysfunction of 15 children with acute lymphoblastic leukemia in relation to cumulative vincristine exposure. Findings. Almost half of the participants had below-average fine motor skills compared to age-related norms, and 57% of parents observed functional motor problems in their children. No significant associations were found between vincristine, manual dexterity, and functional motor skills. Implications. Early detection and intervention for fine motor difficulties is suggested. Research with a larger sample is necessary to further explore the association of vincristine and fine motor function in this clinical population.
引用
收藏
页码:256 / 264
页数:9
相关论文
共 50 条
  • [1] VINCRISTINE DISPOSITION IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    DEGRAAF, SSN
    BLOEMHOF, H
    VENDRIG, DEMM
    UGES, DRA
    MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (04): : 235 - 240
  • [2] Identifying fine motor difficulties in children with acute lymphoblastic leukemia: a scoping review
    Hanna, Silvia
    El-Ayadi, Moatasem
    Abdelazeim, Faten
    SUPPORTIVE CARE IN CANCER, 2024, 32 (07)
  • [3] GENETIC DETERMINANTS OF VINCRISTINE NEUROPATHY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Skiles, J. L.
    Li, C. H.
    Li, L.
    Renbarger, J. L.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S172 - S172
  • [4] VINCRISTINE TOXICITY IN 5 CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    MURPHY, JA
    ROSS, LM
    GIBSON, BES
    LANCET, 1995, 346 (8972): : 443 - 443
  • [5] Toxicity of Vincristine Combined With Posaconazole in Children With Acute Lymphoblastic Leukemia
    Pekpak, Esra
    Ileri, Talia
    Ince, Elif
    Ertem, Mehmet
    Uysal, Zumrut
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (05) : E309 - E310
  • [6] Investigating fine motor deficits during maintenance therapy in children with acute lymphoblastic leukemia
    Hanna, Silvia
    Elshennawy, Shorouk
    El-Ayadi, Moatasem
    Abdelazeim, Faten
    PEDIATRIC BLOOD & CANCER, 2020, 67 (07)
  • [7] Degradation of vincristine by myeloperoxidase and hypochlorous acid in children with acute lymphoblastic leukemia
    Özgen, O
    Türköz, Y
    Stout, M
    Özugurlu, F
    Pelik, F
    Bulut, Y
    Aslan, M
    Ravindranath, Y
    Savasan, S
    LEUKEMIA RESEARCH, 2003, 27 (12) : 1109 - 1113
  • [8] NEUTROPHIL FUNCTION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    DEMARTINO, M
    GUAZZELLI, C
    BIADAIOLI, R
    COSENZA, E
    NOVEMBRE, E
    PISANU, C
    VIERUCCI, A
    ANNALI SCLAVO, 1977, 19 (05): : 1109 - 1118
  • [9] Pharmacokinetics of vincristine in infants with acute lymphoblastic leukemia
    Bomgaars, L
    Hunter, C
    Huang, R
    Schmidt, M
    Dreyer, Z
    Blaney, S
    Berg, S
    Murry, DJ
    BLOOD, 2004, 104 (11) : 209B - 209B
  • [10] Severe Vincristine Toxicity in Acute Lymphoblastic Leukemia
    Bhuta, R.
    DeNardo, B.
    Cole, P.
    Matook, K.
    Welch, J.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S169 - S169